GAM
BMRN icon

Griffin Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Griffin Asset Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,678
Closed -$1.37M – 214
2024
Q2 		$1.37M Sell
16,678
-760
-4% -$63.3K 0.16% 113
2024
Q1 		$1.52M Sell
17,438
-35
-0.2% -$3.13K 0.18% 109
2023
Q4 		$1.68M Buy
17,473
+453
+3% +$40.1K 0.21% 98
2023
Q3 		$1.51M Hold
17,020
– – 0.21% 101
2023
Q2 		$1.48M Buy
17,020
+2,175
+15% +$205K 0.2% 108
2023
Q1 		$1.44M Sell
14,845
-111
-0.7% -$11.5K 0.2% 106
2022
Q4 		$1.55M Buy
+14,956
New +$1.4M 0.23% 103
2022
Q2 		– Sell
-4,640
Closed -$358K – 215
2022
Q1 		$358K Sell
4,640
-7,330
-61% -$613K 0.05% 182
2021
Q4 		$1.06M Buy
11,970
+540
+5% +$44.6K 0.13% 141
2021
Q3 		$883K Sell
11,430
-485
-4% -$38.3K 0.11% 149
2021
Q2 		$994K Sell
11,915
-1,735
-13% -$138K 0.12% 142
2021
Q1 		$1.03M Buy
13,650
+2,365
+21% +$193K 0.13% 134
2020
Q4 		$990K Buy
11,285
+210
+2% +$16.6K 0.13% 126
2020
Q3 		$843K Buy
11,075
+305
+3% +$30.9K 0.13% 123
2020
Q2 		$1.33M Sell
10,770
-75
-0.7% -$7.45K 0.21% 92
2020
Q1 		$916K Buy
+10,845
New +$934K 0.17% 104
2019
Q3 		– Sell
-235
Closed -$20K – 257
2019
Q2 		$20K Buy
+235
New +$20.1K ﹤0.01% 425

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Griffin Asset Management's BMRN Position: Q3 2024 in Review

Griffin Asset Management sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2024, closing a stake of 16,678 shares — an estimated $1.37M sold.

Griffin Asset Management first reported a position in BMRN in Q2 2019 and held it in 17 quarters. The position peaked at $1.68M in Q4 2023. 553 funds tracked by Wall St. Rank hold BMRN as of Q3 2024.

  • Griffin Asset Management reported no remaining BioMarin Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Griffin Asset Management sold 16,678 BioMarin Pharmaceuticals shares in Q3 2024, an estimated $1.37M.
  • Griffin Asset Management first reported a position in BioMarin Pharmaceuticals in Q2 2019 and held it in 17 quarters.
  • Griffin Asset Management's BioMarin Pharmaceuticals position peaked at $1.68M in Q4 2023.
  • 553 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2024.

Based on Griffin Asset Management's 13F filing for Q3 2024, filed 15 Oct 2024.